$OM
Outset Medical, Inc.

2020 Q4 Form 10-Q Financial Statement

#000156459020053315 Filed on November 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $17.25M $13.76M $2.630M
YoY Change 143.43% 423.04%
Cost Of Revenue $16.83M $18.88M $7.924M
YoY Change 138.29%
Gross Profit $417.0K -$5.126M -$5.294M
YoY Change -115.0% -3.17%
Gross Profit Margin 2.42% -37.26% -201.29%
Selling, General & Admin $24.25M $26.43M $7.448M
YoY Change 254.89%
% of Gross Profit 5815.35%
Research & Development $7.780M $9.175M $5.708M
YoY Change 60.74%
% of Gross Profit 1865.71%
Depreciation & Amortization $1.930M $540.0K
YoY Change 168.06%
% of Gross Profit 462.83%
Operating Expenses $32.03M $35.61M $13.16M
YoY Change 170.65%
Operating Profit -$31.61M -$40.73M -$18.45M
YoY Change 120.78%
Interest Expense -$430.0K $428.0K $1.047M
YoY Change -59.12%
% of Operating Profit
Other Income/Expense, Net $0.00 -$3.000K $569.0K
YoY Change -100.53%
Pretax Income -$32.04M -$42.29M -$15.38M
YoY Change 174.96%
Income Tax $0.00 $20.00K
% Of Pretax Income
Net Earnings -$32.04M -$42.29M -$15.40M
YoY Change 64.78% 174.6%
Net Earnings / Revenue -185.79% -307.46% -585.63%
Basic Earnings Per Share -$0.75 -$3.44
Diluted Earnings Per Share -$0.75 -$3.44
COMMON SHARES
Basic Shares Outstanding 42.70M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $314.9M $344.2M
YoY Change
Cash & Equivalents $295.0M $311.3M $39.22M
Short-Term Investments $19.90M $32.90M
Other Short-Term Assets $6.200M $4.700M
YoY Change
Inventory $18.38M $11.81M
Prepaid Expenses
Receivables $6.468M $7.082M
Other Receivables $0.00 $0.00
Total Short-Term Assets $345.9M $367.8M
YoY Change 334.31%
LONG-TERM ASSETS
Property, Plant & Equipment $15.00M $14.41M
YoY Change 89.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.356M $1.977M
YoY Change 1553.66%
Total Long-Term Assets $57.92M $58.20M
YoY Change 564.2%
TOTAL ASSETS
Total Short-Term Assets $345.9M $367.8M
Total Long-Term Assets $57.92M $58.20M
Total Assets $403.8M $426.0M
YoY Change 357.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.948M $5.062M
YoY Change -0.24%
Accrued Expenses $26.60M $22.40M
YoY Change
Deferred Revenue $3.201M $4.132M
YoY Change 262.51%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $36.69M $33.04M
YoY Change 47.3%
LONG-TERM LIABILITIES
Long-Term Debt $29.67M $29.65M
YoY Change 37.63%
Other Long-Term Liabilities $8.900M $9.000M
YoY Change
Total Long-Term Liabilities $29.67M $29.65M
YoY Change 37.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $36.69M $33.04M
Total Long-Term Liabilities $29.67M $29.65M
Total Liabilities $75.22M $71.69M
YoY Change 47.18%
SHAREHOLDERS EQUITY
Retained Earnings -$494.1M -$462.0M
YoY Change 32.61%
Common Stock $822.7M $816.3M
YoY Change 229695.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $328.6M $354.3M -$353.1M
YoY Change
Total Liabilities & Shareholders Equity $403.8M $426.0M
YoY Change 357.0%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$32.04M -$42.29M -$15.40M
YoY Change 64.78% 174.6%
Depreciation, Depletion And Amortization $1.930M $540.0K
YoY Change 168.06%
Cash From Operating Activities -$25.84M -$29.12M
YoY Change -18.74%
INVESTING ACTIVITIES
Capital Expenditures -$2.660M -$1.460M
YoY Change 171.43%
Acquisitions
YoY Change
Other Investing Activities $13.02M -$30.42M
YoY Change -77.74%
Cash From Investing Activities $10.36M -$31.88M
YoY Change -81.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -880.0K 259.8M
YoY Change 1366.67%
NET CHANGE
Cash From Operating Activities -25.84M -29.12M
Cash From Investing Activities 10.36M -31.88M
Cash From Financing Activities -880.0K 259.8M
Net Change In Cash -16.36M 198.8M
YoY Change -163.78%
FREE CASH FLOW
Cash From Operating Activities -$25.84M -$29.12M
Capital Expenditures -$2.660M -$1.460M
Free Cash Flow -$23.18M -$27.66M
YoY Change -24.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Transition Report
DocumentTransitionReport
false
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Shell Company
EntityShellCompany
false
dei Entity Bankruptcy Proceedings Reporting Current
EntityBankruptcyProceedingsReportingCurrent
true
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42700611
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
311327000
CY2020Q3 us-gaap Short Term Investments
ShortTermInvestments
32888000
dei Entity Registrant Name
EntityRegistrantName
Outset Medical, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001484612
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-0514392
dei Entity Address Address Line1
EntityAddressAddressLine1
3052 Orchard Dr.
dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95134
dei City Area Code
CityAreaCode
669
dei Local Phone Number
LocalPhoneNumber
231-8200
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7082000
CY2020Q3 us-gaap Inventory Net
InventoryNet
11810000
CY2019Q4 us-gaap Inventory Net
InventoryNet
4596000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4717000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1058000
dei Amendment Flag
AmendmentFlag
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
OM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7895000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36926000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
33152000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3914000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
357000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
22000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-372567000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-372187000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
367824000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
79646000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
88366000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7993000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18882000
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
33311000
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
743000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14412000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8498000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1977000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82000
CY2020Q3 us-gaap Assets
Assets
426022000
CY2019Q4 us-gaap Assets
Assets
88366000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5062000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4960000
CY2020Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
10850000
CY2019Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
6956000
CY2020Q3 om Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
8959000
CY2019Q4 om Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2909000
CY2020Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3258000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1702000
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4132000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
883000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
782000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
33043000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24910000
CY2020Q3 om Accrued Interest Noncurrent
AccruedInterestNoncurrent
119000
CY2019Q4 om Accrued Interest Noncurrent
AccruedInterestNoncurrent
217000
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
566000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
134000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8309000
CY2019Q4 om Redeemable Convertible Preferred Stock Warrant Liability
RedeemableConvertiblePreferredStockWarrantLiability
4285000
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29652000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21561000
CY2020Q3 us-gaap Liabilities
Liabilities
71689000
CY2019Q4 us-gaap Liabilities
Liabilities
51107000
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
42000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
816306000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-462016000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
354333000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
426022000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42701000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-15402000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6641000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
922000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42701000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
922000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13756000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2630000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32688000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7924000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46142000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23015000
CY2020Q3 us-gaap Gross Profit
GrossProfit
-5126000
CY2019Q3 us-gaap Gross Profit
GrossProfit
-5294000
us-gaap Gross Profit
GrossProfit
-13454000
us-gaap Gross Profit
GrossProfit
-15022000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9175000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5708000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21066000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16698000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13344000
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5009000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
29870000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13376000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13088000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2439000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21462000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
35607000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
13156000
us-gaap Operating Expenses
OperatingExpenses
72398000
us-gaap Operating Expenses
OperatingExpenses
36715000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-40733000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-18450000
us-gaap Operating Income Loss
OperatingIncomeLoss
-85852000
us-gaap Operating Income Loss
OperatingIncomeLoss
-51737000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
569000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
524000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2111000
CY2020Q3 us-gaap Interest Expense
InterestExpense
428000
CY2019Q3 us-gaap Interest Expense
InterestExpense
1047000
us-gaap Interest Expense
InterestExpense
2461000
us-gaap Interest Expense
InterestExpense
3237000
CY2020Q3 om Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
437000
CY2019Q3 om Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
3546000
om Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
-93000
om Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
4030000
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1567000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1567000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42294000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15382000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-89449000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48833000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-42294000
us-gaap Net Income Loss
NetIncomeLoss
-89449000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-26505000
CY2020Q1 om Deemed Dividend On Settlement Of Accrued Dividend
DeemedDividendOnSettlementOfAccruedDividend
42530000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-334076000
CY2020Q3 om Conversion Of Redeemable Convertible Preferred Stock Warrants To Common Stock Warrants Value
ConversionOfRedeemableConvertiblePreferredStockWarrantsToCommonStockWarrantsValue
1252000
us-gaap Net Income Loss
NetIncomeLoss
-48853000
CY2020Q3 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-42294000
CY2019Q3 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-16666000
om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-47281000
om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-66015000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.44
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-18.93
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.30
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-78.77
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12299000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
880000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7508000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
838000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-21000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
102000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42293000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15410000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-89470000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48751000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
41763000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
580000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-35000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
362000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20650000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-308347000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
80000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
683000
CY2020Q3 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
3126000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1050000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13908000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-287950000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
76000
CY2019Q1 om Exercise Of Warrants For Common Stock
ExerciseOfWarrantsForCommonStock
76000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
239000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
82000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
7870000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-16422000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-311769000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
162000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
161000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
28000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
8028000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-17029000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-336475000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
236000
CY2019Q3 om Gain On Extinguishment Of Redeemable Convertible Preferred Stock
GainOnExtinguishmentOfRedeemableConvertiblePreferredStock
117417000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
118862000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-353078000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1229000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
5397000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1112000
om Non Cash Lease Expense
NonCashLeaseExpense
351000
om Repayment Of Term Loan And Extinguishment Costs
RepaymentOfTermLoanAndExtinguishmentCosts
30985000
om Non Cash Lease Expense
NonCashLeaseExpense
337000
om Non Cash Interest Expense
NonCashInterestExpense
497000
om Non Cash Interest Expense
NonCashInterestExpense
691000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-60000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
940000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
29000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
267000
om Provision For Inventories
ProvisionForInventories
443000
om Provision For Inventories
ProvisionForInventories
199000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-293000
us-gaap Share Based Compensation
ShareBasedCompensation
15171000
us-gaap Share Based Compensation
ShareBasedCompensation
636000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3197000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3298000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9236000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5611000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
101000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
368000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
838000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3894000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
991000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
5136000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1237000
om Increase Decrease In Accrued Warranty Liability
IncreaseDecreaseInAccruedWarrantyLiability
1556000
om Increase Decrease In Accrued Warranty Liability
IncreaseDecreaseInAccruedWarrantyLiability
839000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3681000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
667000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-217000
om Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
241000
om Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-374000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-73175000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-55100000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6446000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2764000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
32884000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
88103000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
32919000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
152368000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6411000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
61501000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
255728000
om Proceeds From Issuance Of Cash Exercise Of Redeemable Convertible Preferred Stock Warrant
ProceedsFromIssuanceOfCashExerciseOfRedeemableConvertiblePreferredStockWarrant
4288000
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
126758000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1144000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
254000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
76000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
29630000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
8000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6000
om Payment Of Redeemable Convertible Preferred Stock Issuance Costs
PaymentOfRedeemableConvertiblePreferredStockIssuanceCosts
181000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
386555000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
143000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
306969000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6544000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
344638000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37669000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33415000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
39959000
us-gaap Income Taxes Paid
IncomeTaxesPaid
35000
us-gaap Interest Paid Net
InterestPaidNet
2181000
us-gaap Interest Paid Net
InterestPaidNet
2546000
om Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
374000
om Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability For Conversion Of Series A Warrants Into Common Stock Warrants
ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiabilityForConversionOfSeriesAWarrantsIntoCommonStockWarrants
1252000
om Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability To Additional Paid In Capital
ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiabilityToAdditionalPaidInCapital
3126000
om Conversion Of Redeemable Convertible Preferred Stock Into Common Stock Upon Initial Public Offering
ConversionOfRedeemableConvertiblePreferredStockIntoCommonStockUponInitialPublicOffering
456561000
om Initial Public Offering Issuance Costs Included In Accrued Expenses
InitialPublicOfferingIssuanceCostsIncludedInAccruedExpenses
923000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8849000
om Transfer Of Property And Equipment To Inventories
TransferOfPropertyAndEquipmentToInventories
1579000
us-gaap Stock Issued1
StockIssued1
41763000
om Deemed Dividend On Settlement Of Accrued Dividend
DeemedDividendOnSettlementOfAccruedDividend
42530000
om Capital Expenditures Included In Accounts Payable And Accrued Expenses
CapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses
601000
om Capital Expenditures Included In Accounts Payable And Accrued Expenses
CapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses
294000
om Gain On Extinguishment Of Redeemable Convertible Preferred Stock Before Cost Adjustment
GainOnExtinguishmentOfRedeemableConvertiblePreferredStockBeforeCostAdjustment
117598000
om Adjustment To Redemption Value On Redeemable Convertible Preferred Stock
AdjustmentToRedemptionValueOnRedeemableConvertiblePreferredStock
362000
om Adjustment To Redemption Value On Redeemable Convertible Preferred Stock
AdjustmentToRedemptionValueOnRedeemableConvertiblePreferredStock
134760000
CY2020Q3 us-gaap Change In Accounting Principle Accounting Standards Update Adoption Date
ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
2020-01-01
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Use of Estimates</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">The preparation of the accompanying condensed financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying condensed financial statements and the reported amounts of revenue and expenses. These judgments, estimates and assumptions are used for, but not limited to, revenue recognition, allowance for doubtful accounts, inventory valuation and write-downs, warranty obligations, the fair value of common stock and redeemable convertible preferred stock, the fair value of stock options, the fair value of the redeemable convertible preferred stock warrant liability, valuation of investments, recoverability of the Company&#8217;s net deferred tax assets and the related valuation allowance, and certain accrued expenses. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results may differ from those estimates under different assumptions or conditions and the differences may be material. </font></p>
CY2020Q3 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
false
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2003-05-05
CY2020Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
254800000
CY2020Q3 om Offering Costs Underwriting Discounts And Commissions Expenses
OfferingCostsUnderwritingDiscountsAndCommissionsExpenses
23100000
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
In September 2020, the Company’s board of directors and shareholders approved a certificate of amendment to the amended and restated certificate of incorporation to effect a reverse split of shares of the Company’s common stock on a 7.9-for-one basis (the “Reverse Stock Split”) effective as of September 8, 2020.
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.126582
CY2020Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
344200000
CY2020Q3 om Cash Cash Equivalents Restricted Cash And Short Term Investments
CashCashEquivalentsRestrictedCashAndShortTermInvestments
377500000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39216000
CY2019Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
743000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
344638000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39959000
om Capitalized Contract Cost Amortization Period Description
CapitalizedContractCostAmortizationPeriodDescription
The Company applies the practical expedient to expense the commissions as incurred as the expected amortization period is one year or less.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2020Q3 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201813Member
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4700000
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4100000
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
600000
CY2020Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
30000000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1017000
CY2019Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
30000000
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4698000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
800000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3808000
CY2019 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2578000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2252000
CY2019 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1169000
CY2020Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
0
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
0
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
6163000
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1143000
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
2758000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
842000
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2889000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2611000
CY2020Q3 om Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
1878000
CY2020Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
99000
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
82000
CY2020Q3 om Accrued Inventory Current
AccruedInventoryCurrent
4560000
CY2019Q4 om Accrued Inventory Current
AccruedInventoryCurrent
798000
CY2020Q3 om Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
212000
CY2019Q4 om Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
421000
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2784000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
553000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1403000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1137000
CY2018Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
293000
CY2020Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
348000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
939000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
29652000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
29061000
CY2020Q3 om Preferred Stock Warrants Outstanding
PreferredStockWarrantsOutstanding
0
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13908000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
236000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15171000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
636000
CY2019Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
118862000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
362000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
134760000
CY2019Q3 om Gain On Extinguishment Of Redeemable Convertible Preferred Stock Before Cost Adjustment
GainOnExtinguishmentOfRedeemableConvertiblePreferredStockBeforeCostAdjustment
117598000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4810000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23001000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4810000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23001000

Files In Submission

Name View Source Status
0001564590-20-053315-index-headers.html Edgar Link pending
0001564590-20-053315-index.html Edgar Link pending
0001564590-20-053315.txt Edgar Link pending
0001564590-20-053315-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
om-10q_20200930.htm Edgar Link pending
om-20200930.xml Edgar Link completed
om-20200930.xsd Edgar Link pending
om-20200930_cal.xml Edgar Link unprocessable
om-20200930_def.xml Edgar Link unprocessable
om-20200930_lab.xml Edgar Link unprocessable
om-20200930_pre.xml Edgar Link unprocessable
om-ex311_39.htm Edgar Link pending
om-ex312_38.htm Edgar Link pending
om-ex321_37.htm Edgar Link pending
om-ex322_36.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending